| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3936929
[patent_doc_number] => 05972886
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Megakaryocyte differentiation factor'
[patent_app_type] => 1
[patent_app_number] => 8/611977
[patent_app_country] => US
[patent_app_date] => 1996-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 15817
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972886.pdf
[firstpage_image] =>[orig_patent_app_number] => 611977
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/611977 | Megakaryocyte differentiation factor | Mar 5, 1996 | Issued |
| 90/004156 | RECOMBINANT DNA TRANSFER VECTORS | Feb 28, 1996 | Issued |
| 08/607485 | GDF-1 | Feb 26, 1996 | Abandoned |
Array
(
[id] => 3868976
[patent_doc_number] => 05837681
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-17
[patent_title] => 'Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product'
[patent_app_type] => 1
[patent_app_number] => 8/606176
[patent_app_country] => US
[patent_app_date] => 1996-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17009
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/837/05837681.pdf
[firstpage_image] =>[orig_patent_app_number] => 606176
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/606176 | Method for treating sensorineural hearing loss using glial cell line-derived neurotrophic factor (GDNF) protein product | Feb 22, 1996 | Issued |
| 08/600626 | LOW PH RNA ISOLATION REAGENTS, METHOD, AND KIT | Feb 12, 1996 | Abandoned |
Array
(
[id] => 3994444
[patent_doc_number] => 05892003
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Ciliary neurotrophic factor receptor antibodies'
[patent_app_type] => 1
[patent_app_number] => 8/585258
[patent_app_country] => US
[patent_app_date] => 1996-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 19
[patent_no_of_words] => 20981
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/892/05892003.pdf
[firstpage_image] =>[orig_patent_app_number] => 585258
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/585258 | Ciliary neurotrophic factor receptor antibodies | Jan 10, 1996 | Issued |
| 08/583491 | GDF-1 | Jan 4, 1996 | Abandoned |
Array
(
[id] => 3685412
[patent_doc_number] => 05663069
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-02
[patent_title] => 'Modified lambda bacteriophage'
[patent_app_type] => 1
[patent_app_number] => 8/590708
[patent_app_country] => US
[patent_app_date] => 1995-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 8399
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/663/05663069.pdf
[firstpage_image] =>[orig_patent_app_number] => 590708
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/590708 | Modified lambda bacteriophage | Dec 7, 1995 | Issued |
| 08/561560 | PRODUCTION OF VASCULAR ENDOTHELIAL CELL GROWTH FACTOR AND DNA ENCODING SAME | Nov 21, 1995 | Abandoned |
Array
(
[id] => 3820574
[patent_doc_number] => 05759521
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-02
[patent_title] => 'Method of altering perception of relative space of an area'
[patent_app_type] => 1
[patent_app_number] => 8/557528
[patent_app_country] => US
[patent_app_date] => 1995-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3687
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/759/05759521.pdf
[firstpage_image] =>[orig_patent_app_number] => 557528
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/557528 | Method of altering perception of relative space of an area | Nov 13, 1995 | Issued |
Array
(
[id] => 3949292
[patent_doc_number] => 05977300
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/531864
[patent_app_country] => US
[patent_app_date] => 1995-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 20
[patent_no_of_words] => 11209
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977300.pdf
[firstpage_image] =>[orig_patent_app_number] => 531864
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/531864 | Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof | Sep 20, 1995 | Issued |
Array
(
[id] => 3922532
[patent_doc_number] => 05914236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-22
[patent_title] => 'PCT-65 serotonin receptor'
[patent_app_type] => 1
[patent_app_number] => 8/428243
[patent_app_country] => US
[patent_app_date] => 1995-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 10505
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/914/05914236.pdf
[firstpage_image] =>[orig_patent_app_number] => 428243
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/428243 | PCT-65 serotonin receptor | Sep 17, 1995 | Issued |
| 08/428242 | ST-B17 SEROTONIN RECEPTOR | Sep 17, 1995 | Abandoned |
Array
(
[id] => 4046691
[patent_doc_number] => 05912326
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-15
[patent_title] => 'Cerebellum-derived growth factors'
[patent_app_type] => 1
[patent_app_number] => 8/525864
[patent_app_country] => US
[patent_app_date] => 1995-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 33088
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/912/05912326.pdf
[firstpage_image] =>[orig_patent_app_number] => 525864
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/525864 | Cerebellum-derived growth factors | Sep 7, 1995 | Issued |
Array
(
[id] => 3847451
[patent_doc_number] => 05766879
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'DNA encoding 5-HT.sub.4 serotonin receptors and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/446822
[patent_app_country] => US
[patent_app_date] => 1995-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 33
[patent_no_of_words] => 23974
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/766/05766879.pdf
[firstpage_image] =>[orig_patent_app_number] => 446822
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/446822 | DNA encoding 5-HT.sub.4 serotonin receptors and uses thereof | Jul 30, 1995 | Issued |
Array
(
[id] => 3784915
[patent_doc_number] => 05840542
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-24
[patent_title] => 'Method for manufacture of proinsulin with high export yield'
[patent_app_type] => 1
[patent_app_number] => 8/508664
[patent_app_country] => US
[patent_app_date] => 1995-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 5879
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/840/05840542.pdf
[firstpage_image] =>[orig_patent_app_number] => 508664
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/508664 | Method for manufacture of proinsulin with high export yield | Jul 27, 1995 | Issued |
Array
(
[id] => 4205540
[patent_doc_number] => 06027906
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-22
[patent_title] => 'Penicillin binding protein derivatives and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/481435
[patent_app_country] => US
[patent_app_date] => 1995-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 28
[patent_no_of_words] => 31029
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/027/06027906.pdf
[firstpage_image] =>[orig_patent_app_number] => 481435
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/481435 | Penicillin binding protein derivatives and uses thereof | Jul 9, 1995 | Issued |
Array
(
[id] => 3991627
[patent_doc_number] => 05985585
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Processes using a human serotonin receptor (5-HT.sub.4B)'
[patent_app_type] => 1
[patent_app_number] => 8/157185
[patent_app_country] => US
[patent_app_date] => 1995-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 25451
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985585.pdf
[firstpage_image] =>[orig_patent_app_number] => 157185
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/157185 | Processes using a human serotonin receptor (5-HT.sub.4B) | Jun 14, 1995 | Issued |
| 08/483222 | DNA ENCODING A HUMAN 5-HT1F RECEPTOR AND USES THEREOF | Jun 6, 1995 | Abandoned |
Array
(
[id] => 4029747
[patent_doc_number] => 05942222
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-24
[patent_title] => 'Methods of treating granulocyte-macrophage progenitor cell-derived blood cell dysfunction'
[patent_app_type] => 1
[patent_app_number] => 8/476379
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8123
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/942/05942222.pdf
[firstpage_image] =>[orig_patent_app_number] => 476379
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/476379 | Methods of treating granulocyte-macrophage progenitor cell-derived blood cell dysfunction | Jun 6, 1995 | Issued |